Pharmafile Logo
Pharmafocus logo
Advanced Search

Trump

Showing 6 posts of 111 posts found.

Does Trump pose a threat to the FDA’s future?

February 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump

President Trump’s first month in office made headlines across the industry just as it did in the wider media. Promises …

Feature
pharmafocus_march_cover

The March 2017 issue of Pharmafocus is now live!

February 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, FDA, Johnson & Johnson, MSD, Roche, Trump, crispr, immunotherapy, opdivo

The latest edition of Pharmafocus is available to read online now! From breakthroughs in antibiotic resistance R&D to gene editing …

News
donald_trump_september_3_2015

What does Trump’s victory mean for the pharma, biotech and healthcare sectors?

February 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Trump

After his first month in office and numerous threats to big pharma, finnCap Life Sciences analysts Alex Pye and Mark …

Feature
donald_trump_september_3_2015

Trump meets with top pharma execs, reiterates pledge to lower “astronomical” prices

January 31, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Eli Lilly, Novartis, PhRMA, Trump

President Trump convened with a number of top pharma execs at the White House on Tuesday to discuss the key …

News

Trump’s “one in, two out” regulatory order threatens FDA, Obama Cures Act

January 31, 2017
Manufacturing and Production, Sales and Marketing FDA, Trump

An executive order signed by President Donald Trump on Monday has caused concern in the US pharma industry and beyond …

News
phrma_logo

US Pharma launches multi-million dollar media campaign to deflect pricing criticism

January 24, 2017
Manufacturing and Production, Medical Communications PhMRA, Trump

In response to a number of recent criticisms over pricing including president Trump’s message that pharma companies are “getting away …

News

Latest content

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024

FDA approves Roche’s HPV self-collection screening option

May 15, 2024

NHS accepts Pfizer’s tafamidis for ATTR-CM treatment

May 14, 2024